Skip to content

Promoting urinary continence in people with Parkinson’s disease

Promoting urinary continence in people with Parkinson’s disease - Park-UK

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00007973
Enrollment
50
Registered
2015-04-20
Start date
2015-06-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G20 R32

Interventions

Group 1: Contol-group: usual care (Duration: during the whole stay in the rehabilitation clinic (normally 3 weeks) and support at home up to eight week after discharge) Group 2: Interventiongroup: The

Sponsors

Fachhochschule St.Gallen / Institut für Angewandte Pflegewissenschaft
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: -Parkinson's disease -Urinary incontinence -living at home or in a nursing home after discharge -german speaking

Exclusion criteria

Exclusion criteria: -Urinary catheter - MMST<18 -Depression -Delir, Hallucinations -living in a nursing home

Design outcomes

Primary

MeasureTime frame
Incontinence (pad-test, micturition diary, ICIQ-SF questionnaire, 3 months after discharge) Quality of life (I-QOL questionnaire, 3 months after discharge)

Secondary

MeasureTime frame
Nurses: Knowledge about urinary incontinence and their workload Time of measurement: three points of measurement; at the beginning of the control phase, between the control and intervention phase (before the education of the intervention), at the end of the intervention phase Questionnaire: self-developed questionnaire about knowledge of incontinence, Short Questionnaire for work analysis

Countries

Switzerland

Contacts

Public ContactSusi Saxer

Fachhochschule St.Gallen / Institut für Angewandte Pflegewissenschaft

susi.saxer@fhsg.ch+41 71 226 15 20

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026